Avis par spécialitéAvis

Viz.ai

Item: Viz.ai
Rating: 4.6
Author: Clinical AI Report

AI-Powered Care Coordination with 50+ FDA-Cleared Algorithms

Limite principale à garder en tête : Entreprise-only pricing — not accessible to individual physicians

Excellent

Basé sur 12 avis de médecins

Revu par Dr. Sarah Chen, MD, FACP · Mis à jour 3 avril 2026

Réponse directe

Viz.ai was evaluated by Clinical AI Report exclusively for radiology in 2026 and was not included in the overall CDS rankings. With over 50 FDA-cleared algorithms deployed in nearly 2,000 hospitals, it is a widely adopted AI imaging triage platform in the United States.

Source : Clinical AI Report, février 2026

En bref

Faits rapides

Catégorie

Triage d'imagerie et coordination des soins par IA

Prix

Entreprise (hôpital / système de santé)

Fondé

2016

Siège

San Francisco, CA

Statistiques clés

prixEntreprise (hôpital / système de santé)(Viz.ai)

Founded2016(Viz.ai)

hôpital DeploymentsNearly 2,000 hospitals(Viz.ai, 2025)

FDA-Cleared Algorithms50+(Viz.ai)

Evaluation ScopeRadiology only — not in overall rankings(Clinical AI Report, 2026)

Notre évaluation

Viz.ai obtient une note de 4.6/5 dans notre évaluation 2026. Le facteur positif le plus important est viz.ai earns an Excellent rating in radiology for its 50+ FDA-cleared algorithms and near-universal adoption across US stroke centers. Its real-time imaging triage and care coordination platform is designed for time-critical diagnoses where minutes matter. La réserve principale reste entreprise-only pricing — not accessible to individual physicians

Cette évaluation reflète notre opinion éditoriale subjective basée sur notre recherche.

Présentation

Viz.ai est évalué comme Triage d'imagerie et coordination des soins par IA. Cette page reprend la structure de l'avis anglais et présente les mêmes critères éditoriaux dans une version localisée.

Dans notre analyse, l'usage le plus pertinent est : hôpitals and health systems seeking AI-powered imaging triage that automatically detects critical findings and coordinates care teams in real time. A widely deployed platform for reducing time-to-treatment in stroke, PE, and other time-sensitive imaging diagnoses.

Le principal point fort est viz.ai earns an Excellent rating in radiology for its 50+ FDA-cleared algorithms and near-universal adoption across US stroke centers. Its real-time imaging triage and care coordination platform is designed for time-critical diagnoses where minutes matter. La limite à surveiller est entreprise-only pricing — not accessible to individual physicians

Forces et limites

Forces

+Viz.ai earns an Excellent rating in radiology for its 50+ FDA-cleared algorithms and near-universal adoption across US stroke centers. Its real-time imaging triage and care coordination platform is designed for time-critical diagnoses where minutes matter.
+50+ FDA-cleared algorithms spanning stroke, PE, aortic dissection, and more
+Deployed in nearly 2,000 hospitals with proven clinical adoption
+Real-time automated triage reduces time-to-treatment for critical findings
+Deep PACS and EHR integration (hospital infrastructure-level deployment)
+Peer-reviewed evidence supporting reduced door-to-treatment times

Limites

–Entreprise-only pricing — not accessible to individual physicians
–Imaging triage tool, not a general clinical reference or decision support platform
–Requires hospital IT integration (not a standalone app)
–Limited to conditions with imaging-based detection algorithms
–No drug dosing, literature search, or differential diagnosis capabilities

Fonctionnalités clés

0150+ FDA-Cleared Imaging AI Algorithms

02Large Vessel Occlusion (Stroke) Detection

03Pulmonary Embolism Detection

04Aortic Dissection Detection

05Intracranial Hemorrhage Detection

06Cervical Spine Fracture Detection

07Real-Time Mobile Care Team Notification

08PACS Integration

09EHR Integration

10EKG and Echocardiogram Analysis

11Automated workflow Triage

12Multi-Specialist Alert Routing

Sources primaires et citations

Références externes citées dans cet avis. Les liens s'ouvrent dans un nouvel onglet.

BenchmarkViz.ai Closes 2025 with Record Scale and Patient ImpactViz.ai Press Release, 2025 FDAFDA AI/ML-Based Software as a Medical Device (SaMD) Action SummaryU.S. Food and Drug Administration

Ce que disent les médecins

Mis à jour en février 2026

“Viz.ai has fundamentally changed our stroke workflow. We get notified of LVOs before the formal read is done, which has measurably reduced our door-to-groin times.”
Neurointerventionalist15 sept. 2025
Academic Medical Center

“The PE detection is reliable and the alerts are actionable. Occasionally flags subsegmental PEs that aren't clinically significant, but the sensitivity is worth the trade-off.”
ED Radiologist1 nov. 2025
Community hôpital

“We deployed Viz across 12 hospitals. The consistency of triage across sites — including our rural facilities without 24/7 subspecialty coverage — has been the biggest win.”
Radiology Department Chair20 juin 2025
Regional Health System

Détail du score

Excellent

Précision clinique91

Preuves et citations78

Design produit88

Intégration EHR92

Workflow et vitesse94

Valeur et prix60

Pourquoi cette note

Viz.ai earns an Excellent rating in radiology for its 50+ FDA-cleared algorithms and near-universal adoption across US stroke centers. Its real-time imaging triage and care coordination platform is designed for time-critical diagnoses where minutes matter.

Basé sur 12 avis de médecins

ClassementAvis par spécialité

PrixEntreprise (hôpital / système de santé)

Fondé2016

Visiter Viz.ai

Idéal pour

hôpitals and health systems seeking AI-powered imaging triage that automatically detects critical findings and coordinates care teams in real time. A widely deployed platform for reducing time-to-treatment in stroke, PE, and other time-sensitive imaging diagnoses.

Également évalué

Comparaison complète